v3.26.1
Organization - Schedule of Direct and Indirect Interests in Subsidiaries (Details)
12 Months Ended
Dec. 31, 2025
YD Biopharma Limited (“YD Biopharma”) [Member]  
Schedule of Direct and Indirect Interests in Subsidiaries [Line Items]  
Date of Incorporation Mar. 14, 2024
Place of Incorporation Cayman
Shareholders YD Bio
% of Equity Ownership 100.00%
Principal Activities Holding
Yong Ding Biopharm Co., Ltd (“Yong Ding”) [Member]  
Schedule of Direct and Indirect Interests in Subsidiaries [Line Items]  
Date of Incorporation Apr. 23, 2013
Place of Incorporation the Republic of China (“ROC” or “Taiwan”)
Shareholders YD Biopharma
% of Equity Ownership 100.00%
Principal Activities Sales of drugs, medical and related products in Taiwan
YD BIO USA INC. (“YD USA”) [Member]  
Schedule of Direct and Indirect Interests in Subsidiaries [Line Items]  
Date of Incorporation Feb. 04, 2025
Place of Incorporation Delaware (US)
Shareholders YD Biopharma
% of Equity Ownership 100.00%
Principal Activities Sales of drugs, medical and related products in US
YD PharmaWings Limited (“YD PharmaWings”) [Member]  
Schedule of Direct and Indirect Interests in Subsidiaries [Line Items]  
Date of Incorporation Oct. 23, 2025
Place of Incorporation BVI
Shareholders YD Biopharma
% of Equity Ownership 100.00%
Principal Activities Investment holding
Breeze Holdings Acquisition Corp (“Breeze”) [Member]  
Schedule of Direct and Indirect Interests in Subsidiaries [Line Items]  
Date of Incorporation Mar. 03, 2021
Place of Incorporation Delaware (US)
Shareholders YD Bio
% of Equity Ownership 100.00%
Principal Activities Dissolved in December 2025